Duratocin

Duratocin is a pharmaceutical product containing Carbetocin, used for specific medical conditions. This intravenous medication is manufactured by Ferring Léciva A.S. in the EU.

Duratocin, containing the active ingredient Carbetocin, is primarily used to address certain medical conditions related to uterine health. It is often administered intravenously to support specific therapeutic needs. Carbetocin is known for its role in promoting uterine contractions, which can be beneficial in various clinical scenarios.

When administered, Duratocin may induce uterine contractions, which can help in managing certain post-partum conditions. The effects are typically observed shortly after intravenous administration. Patients may experience a range of responses, and it is important to monitor for any adverse reactions.

Duratocin should be handled with care and administered by healthcare professionals. It is crucial to follow proper medical guidelines and precautions when using this medication. Patients with certain medical conditions may need to exercise caution, and it is important to consult with a healthcare provider before use.

Duratocin may interact with other medications, particularly those that affect uterine contractions or blood pressure. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain other substances may also influence the effects of Duratocin.